Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Lees

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2008
Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignanciesXin Huang, Hongfeng Guo, Johnthomas Kang, et al.
NPJ Regenerative Medicine|March 3, 2017
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosaBeau R Webber, Mark J Osborn, Amber N McElroy, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2017
Rapid generation of Col7a1<sup>-/-</sup> mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cellsBeau R Webber, Kyle T O'Connor, Ron T McElmurry, et al.
JCI Insight|October 4, 2019
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethalityAsim Saha, Patricia A Taylor, Christopher J Lees, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2008
Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignanciesXin Huang, Hongfeng Guo, Johnthomas Kang, et al.
NPJ Regenerative Medicine|March 3, 2017
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosaBeau R Webber, Mark J Osborn, Amber N McElroy, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 12, 2017
Rapid generation of Col7a1<sup>-/-</sup> mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cellsBeau R Webber, Kyle T O'Connor, Ron T McElmurry, et al.
JCI Insight|October 4, 2019
Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethalityAsim Saha, Patricia A Taylor, Christopher J Lees, et al.
Pageof 2